Skip to main content
Hiten Patel, MD, Urology, Chicago, IL

HitenDilipPatelMDMPH(He/Him)

Urology Chicago, IL

Minimally Invasive Surgery, Surgical Oncology

Assistant Professor of Urology

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile

Already have an account?

  • Office

    675 N St Clair St
    Ste 20-150, Galter Pavilion
    Chicago, IL 60611
    Phone+1 312-695-8146

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2020 - 2022
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Urology, 2014 - 2020
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2014

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2024 - 2026
  • IL State Medical License
    IL State Medical License 2020 - 2026
  • IN State Medical License
    IN State Medical License 2024 - 2025
  • WI State Medical License
    WI State Medical License 2024 - 2025
  • TX State Medical License
    TX State Medical License 2024 - 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Hospitalization and Readmission Costs After Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter?  
    Hiten D Patel, Meera R Chappidi, Trinity J Bivalacqua, Gregory A Joice, Phillip M Pierorazio, Max Kates, Nikolai A Sopko, BJU International

Authored Content

  • Human Penile Transplantation: An Unjustified Ethical Dilemma?June 2018
  • Active Surveillance of Small Renal Masses: A Safe Management Strategy for Select PatientsApril 2018

Press Mentions

  • Improving Prostate Cancer Outcomes for Latino Men Through Awareness
    Improving Prostate Cancer Outcomes for Latino Men Through AwarenessNovember 5th, 2022
  • DCVAC/PCa Use Alongside Chemotherapy Shows No Additional mCRPC Survival Benefit
    DCVAC/PCa Use Alongside Chemotherapy Shows No Additional mCRPC Survival BenefitFebruary 28th, 2022
  • Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer
    Active Cellular Immunotherapy Disappoints in Metastatic Prostate CancerFebruary 10th, 2022
  • Join now to see all